IPO Listed
Suzhou Ribo Life Science Co. IPO
HK$1.8bn raised
HKEX: 6938
Advisers
Suzhou Ribo Life Science Co.
Issuer
- Legal adviser
- Issuer
- Suzhou Ribo Life Science Co.
- Issuer based in
- China
- Listed
- Jan 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development, Pharma
Similar deals
- Latigo Biotherapeutics IPO Aug 2026 · US$346m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- ADARx Pharmaceuticals IPO Sep 2026 · US$446m · Biotech
- ADARx Pharmaceuticals placement Sep 2026 · US$89m · Biotech
- Electra Therapeutics IPO Sep 2026 · US$350m · Biotech
Sources
- Jan 2026 Kirkland Advises Ribo Life on its Hong Kong IPO kirkland.com

